Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03230032 · ClinicalTrials.gov registry record · NA

Pacifier Activated Device and Mother's Voice in Infants at High-risk for Cerebral Palsy

A NA study, sponsored by Nationwide Children's Hospital.

Completed
Registry status
NA
Development phase
130
Enrollment target

NCT03230032: Completed NA study, sponsored by Nationwide Children's Hospital.

NCT03230032 is a NA study that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 130 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03230032, a NA study, has completed, sponsored by Nationwide Children's Hospital.

COMPLETED
Registry status
NA
Development phase
130 participants
Enrollment target

Study Summary

The study seeks to determine the efficacy of non-nutritive suck (NNS) training using a pacifier-activated device (PAM) with mothers' voice to condition suck-strength and rhythmicity, in improving the feeding and developmental outcomes of infants at high-risk for CP.

Primary Outcome

Continuous measure of suck strength and suck rate during non-nutritive suck via PAM sensor, as well as suck burst pattern and average oral feeding volumes.

Interventions

  • DEVICE pacifier-activated device

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2017-06-09
Est. Completion 2021-07-31
Phase NA
Nationwide Children's Hospital

188 total trials

What the finished NCT03230032 record still lists

NCT03230032 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 1 intervention - of which pacifier-activated device is the first listed.

NCT03230032 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03230032 about?

NCT03230032 is a clinical study titled "Pacifier Activated Device and Mother's Voice in Infants at High-risk for Cerebral Palsy". The study seeks to determine the efficacy of non-nutritive suck (NNS) training using a pacifier-activated device (PAM) with mothers' voice to condition suck-strength and rhythmicity, in improving the feeding and developmental outcomes of infants at high-risk for CP.

What is the current status of trial NCT03230032?

This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2017-06-09. Estimated completion is 2021-07-31.

What interventions are being tested in trial NCT03230032?

The interventions under investigation include: pacifier-activated device (DEVICE).

Who is sponsoring clinical trial NCT03230032?

This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03230032's enrollment target sits among peer trials

130 733rd of 2000 higher than 1,257 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01492036 · 130 participants

    Long-Term Follow-Up of Recipient of Gene Transfer Research

  • NCT01631617 · 130 participants · Phase 2

    Effects of Treatments on Atopic Dermatitis

  • NCT02368041 · 130 participants

    Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure

  • NCT02604277 · 130 participants · NA

    Suicidal Behavior in Patients Diagnosed With Bipolar Disorder

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03230032, the US trial registry maintained by the National Library of Medicine. NCT03230032 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.